Lofibra 134 mg Gate 323 (Lofibra 134 mg)

Generic Name: fenofibrate

Pill imprint Lofibra 134 mg Gate 323 has been identified as Lofibra 134 mg.

Lofibra is used in the treatment of hypertriglyceridemia; hyperlipoproteinemia; hyperlipoproteinemia type iia, elevated ldl; hyperlipoproteinemia type iv, elevated vldl; hyperlipoproteinemia type iib, elevated ldl vldl (and more), and belongs to the drug class fibric acid derivatives. Risk cannot be ruled out during pregnancy. Lofibra 134 mg is not a controlled substance under the Controlled Substance Act (CSA).

Lofibra

Generic Name:

fenofibrate

Imprint:

Lofibra 134 mg Gate 323

Strength:

134 mg

Color:

Blue

Size:

18.00 mm

Shape:

Capsule-shape

Availability:

Prescription only

Drug Class:

Fibric acid derivatives

Pregnancy Category:

C - Risk cannot be ruled out

CSA Schedule:

Not a controlled drug

Manufacturer:

Gate Pharmaceuticals

National Drug Code (NDC):

57844-0323

Inactive Ingredients:

croscarmellose sodium
crospovidone
lactose monohydrate
magnesium stearate
povidone k25
corn starch
sodium lauryl sulfate
D&C Red No. 28
FD&C Blue No. 1
titanium dioxide
gelatin

More info Print Imprint Search

Disclaimer: Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Copyright 2016 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.